Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.

McCloskey M, Wang H, Jiang Y, Smith GW, Strange J, Hartnett ME.

Invest Ophthalmol Vis Sci. 2013 Mar 21;54(3):2020-6. doi: 10.1167/iovs.13-11625.

4.

Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.

Jiang Y, Wang H, Culp D, Yang Z, Fotheringham L, Flannery J, Hammond S, Kafri T, Hartnett ME.

Invest Ophthalmol Vis Sci. 2014 Feb 10;55(2):824-31. doi: 10.1167/iovs.13-13755.

5.

Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.

Budd S, Byfield G, Martiniuk D, Geisen P, Hartnett ME.

Exp Eye Res. 2009 Nov;89(5):718-27. doi: 10.1016/j.exer.2009.06.011. Epub 2009 Jul 1.

6.

Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.

Hartmann JS, Thompson H, Wang H, Kanekar S, Huang W, Budd SJ, Hartnett ME.

Mol Vis. 2011;17:1577-87. Epub 2011 Jun 10.

7.

VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.

Wang H, Byfield G, Jiang Y, Smith GW, McCloskey M, Hartnett ME.

Am J Pathol. 2012 Mar;180(3):1243-53. doi: 10.1016/j.ajpath.2011.11.031. Epub 2012 Jan 9.

8.
9.

The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.

Byfield G, Budd S, Hartnett ME.

Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3360-5. doi: 10.1167/iovs.08-3256. Epub 2009 Mar 5.

10.

Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.

Budd SJ, Thompson H, Hartnett ME.

Arch Ophthalmol. 2010 Aug;128(8):1014-21. doi: 10.1001/archophthalmol.2010.158.

11.

VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis.

Yang Z, Wang H, Jiang Y, Hartnett ME.

Am J Pathol. 2014 Apr;184(4):1230-9. doi: 10.1016/j.ajpath.2013.12.023. Epub 2014 Mar 12.

12.

Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.

Wang H, Yang Z, Jiang Y, Flannery J, Hammond S, Kafri T, Vemuri SK, Jones B, Hartnett ME.

Invest Ophthalmol Vis Sci. 2014 Feb 4;55(2):737-44. doi: 10.1167/iovs.13-13429.

13.

Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

Saito Y, Uppal A, Byfield G, Budd S, Hartnett ME.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1591-8. doi: 10.1167/iovs.07-1356.

14.

[Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].

Liu X, Wang W, Wang AR, Ning Q, Luo XP.

Zhonghua Er Ke Za Zhi. 2007 Jan;45(1):7-13. Chinese.

PMID:
17349140
15.

Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.

Wang H, Smith GW, Yang Z, Jiang Y, McCloskey M, Greenberg K, Geisen P, Culp WD, Flannery J, Kafri T, Hammond S, Hartnett ME.

Am J Pathol. 2013 Sep;183(3):964-74.

16.
18.
19.

Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.

Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch VL.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3107-14. doi: 10.1167/iovs.08-1780. Epub 2008 Mar 31.

20.

Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity.

Ozkan H, Duman N, Kumral A, Kasap B, Ozer EA, Lebe B, Yaman A, Berk T, Yilmaz O, Ozer E.

Physiol Res. 2006;55(3):267-75. Epub 2005 Aug 5.

Supplemental Content

Support Center